Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.94% | 18.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.04% | 15.64% | |||
| Operating Income | 28.04% | -15.64% | |||
| Income Before Tax | 19.75% | -39.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.75% | -39.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.75% | -39.55% | |||
| EBIT | 28.04% | -15.64% | |||
| EBITDA | 28.43% | -17.14% | |||
| EPS Basic | 20.03% | -31.77% | |||
| Normalized Basic EPS | 24.22% | -2.55% | |||
| EPS Diluted | 20.03% | -31.77% | |||
| Normalized Diluted EPS | 24.22% | -2.55% | |||
| Average Basic Shares Outstanding | 0.35% | 5.91% | |||
| Average Diluted Shares Outstanding | 0.35% | 5.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||